A Multicenter Assessment of ALD403 in Frequent Episodic Migraine

See also
Status	Clinical Trial	Phase
Completed	`NCT01432379` - BOTOX® Prophylaxis in Patients With Chronic Migraine
Completed	`NCT04084314` - Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study	Phase 4
Recruiting	`NCT05048914` - Migraine Abortive Treatment
Completed	`NCT03662295` - Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
Completed	`NCT02766517` - Biomarker Study in Participants With Migraine	Early Phase 1
Completed	`NCT00963937` - Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents	Phase 3
Not yet recruiting	`NCT03632928` - Day to Day Variation of Pressure Pain Threshold and Muscle Hardness
Completed	`NCT01435941` - Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine	N/A
Completed	`NCT00743015` - Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks	Phase 1
Completed	`NCT01376141` - Drug Use Investigation for IMIGRAN Tablet	N/A
Completed	`NCT02183688` - Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients	Phase 3
Completed	`NCT06061588` - "Potential Effects of Virtual Reality Technology on the Treatment of Migraine-Type Headaches"	N/A
Completed	`NCT03588364` - The Role of Osteopathic Manipulation in the the Management of Post-traumatic Migraine	N/A
Completed	`NCT04091321` - Association Between Chronic Headache and Back Pain With Childbirth
Completed	`NCT00385008` - TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine	Phase 3
Active, not recruiting	`NCT05888298` - Proximal and Distal Approach GON RFT in Migraine	N/A
Completed	`NCT03435185` - Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients	N/A
Recruiting	`NCT06459635` - Migraine Attack Pain Phase Prediction Study
Completed	`NCT02565186` - An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine	Phase 3
Completed	`NCT05658185` - Migraine Difficult to Treat: the Importance of Psychological Care in the Chronic Patient	N/A

NCT number	NCT02559895
Study type	Interventional
Source	Alder Biopharmaceuticals, Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	September 2015
Completion date	December 2017

A Multicenter Assessment of ALD403 in Frequent Episodic Migraine — PROMISE 1

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms